Evidence map›Paper›PMID 16773571›Full record

ArticleAmerican journal of human genetics2006

Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression.

William S Modi, James Lautenberger, Ping An, Kevin Scott, James J Goedert, Gregory D Kirk, Susan Buchbinder, John Phair, Sharyne Donfield, Stephen J O'Brien and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Neurocognitive Impairment and Associated Genetic Aspects in HIV Infection.Current topics in behavioral neurosciences · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Role of Different Subpopulations of CD8Frontiers in immunology · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.Journal of acquired immune deficiency syndromes (1999) · 2014
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

William S ModiSAIC-Frederick, Inc., Basic Research Program, Frederick, MD 21702-1201, USA.
James Lautenberger
Ping An
Kevin Scott
James J Goedert
Gregory D Kirk
Susan Buchbinder
John Phair
Sharyne Donfield
Stephen J O'Brien
Cheryl Winkler
National Cancer Institute · USScience Applications International Corporation (United States) · USJohns Hopkins University · USNorthwestern University · USRho (United States) · USSan Francisco Department of Public Health · US

Funding

Rapid Analysis of SNP Genotypes in AIDS CohortsZ01BC010317 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI O'BRIEN, STEPHEN J · 1999 to 2008
$2.4M
Identification of Gene Polymorphisms Associated with Infectious DiseasesZ01BC010297 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WINKLER, CHERYL ANN · 1998 to 2008
$1.5M
Intramural NIH HHSNCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400
6 · The paper itself

Abstract

CCL3 (MIP-1 alpha), CCL4 (MIP-1 beta), and CCL18 (DC-CK1/PARC/AMAC-1) are potent chemoattractants produced by macrophages, natural killer cells, fibroblasts, mast cells, CD4(+) T cells, and CD8(+) T cells. CCL3 and CCL4 are natural ligands for the primary human immunodeficiency virus type 1 (HIV-1) coreceptor CCR5 and are also known to activate and enhance the cytotoxicity of natural killer cells. Genomic DNAs from >3,000 participants enrolled in five United States-based natural-history cohorts with acquired immunodeficiency syndrome (AIDS) were genotyped for 21 single-nucleotide polymorphisms (SNPs) in a 47-kb interval on chromosome 17q12 containing the genes CCL3, CCL4, and CCL18. All 21 SNPs were polymorphic in African Americans (AAs), whereas 7 of the 21 had minor-allele frequencies <0.01 in European Americans (EAs). Substantial linkage disequilibrium was observed in a 37-kb interval containing 17 SNPs where many pairwise D' values exceeded 0.70 in both racial groups, but particularly in EAs. Four and three haplotype blocks were observed in AAs and EAs, respectively. Blocks were strongly correlated with each other, and common haplotype diversity within blocks was limited. Two significant associations are reported that replicate an earlier study. First, among AA members of the AIDS Link to the Intravenous Experience cohort of injection drug users, frequencies of three correlated SNPs covering 2,231 bp in CCL3 were significantly elevated among highly exposed, persistently HIV-1-uninfected individuals compared with HIV-1-infected seroconvertors (P = .02-.03). Second, seven highly correlated SNPs spanning 36 kb and containing all three genes were significantly associated with more-rapid disease progression among EAs enrolled in the Multicenter AIDS Cohort Study cohort (P = .01-.02). These results reiterate the importance of chemokine gene variation in HIV-1/AIDS pathogenesis and emphasize that localized linkage disequilibrium makes the identification of causal mutations difficult.

Indexed as

Genetic VariationMultigene FamilyChemokine CCL3Chemokine CCL4Chemokines, CCCohort StudiesDisease ProgressionHIV-1HIV InfectionsHumansLinkage DisequilibriumLongitudinal StudiesMacrophage Inflammatory ProteinsPolymorphism, Single NucleotideCCL18 protein, humanCCL4 protein, humanChemokine CCL3Chemokine CCL4Chemokines, CCMacrophage Inflammatory Proteins

Identifiers

PMID16773571
PMCPMC1474130
OpenAlexW2123589516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.